Global Clinical Safety Management System Industry Context & Pain Points: Drug safety and pharmacovigilance are under growing global scrutiny, driving demand for advanced IT solutions in the life sciences sector. The pharmacovigilance market is projected to grow from $8.6 billion in 2024 to $9.6 billion in 2025, with a CAGR of 12.5% per year until […]
Success Story: Clinical Trial Management Solution Validation & Market Expansion “The life sciences sector is poised for a dynamic year in 2025, with significant developments expected in M&A, PE investments, capital markets, AI, and regulations”, as the experts from Goodwin and KPMG said at the beginning of this year. Dynamic years lead to exceptional opportunities, as […]
Critical Data Migration in Pharma M&A (Ensuring Trial Continuity) Industry Context: The pharmaceutical sector is experiencing a surge in strategic mergers and acquisitions (M&A) deals aimed at bolstering research and development (R&D) pipelines. In just the first half of 2025, big pharma companies inked over $13 billion in acquisitions targeting late-stage drug assets, as shown in […]